<DOC>
	<DOCNO>NCT00004330</DOCNO>
	<brief_summary>OBJECTIVES : Assess whether chronic administration gonadotropin-releasing hormone analogue safe effective prevention cyclic attack acute porphyria woman .</brief_summary>
	<brief_title>Studies Porphyria IV : Gonadotropin-Releasing Hormone ( GnRH ) Analogues Prevention Cyclic Attacks</brief_title>
	<detailed_description>PROTOCOL OUTLINE : All patient receive gonadotropin-releasing hormone ( GnRH ) analogue . Treatment begin day 1 3 menstrual cycle . Low-dose estrogen begin approximately 3 month . All patient must daily calcium intake least 1 gram ; supplement allow . Patients follow least 1 year .</detailed_description>
	<mesh_term>Porphyrias</mesh_term>
	<mesh_term>Porphyria , Erythropoietic</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Acute porphyria , i.e . : Acute intermittent porphyria Hereditary coproporphyria Variegate porphyria Definite cyclic attack severe abdominal pain porphyria symptom luteal phase menstrual cycle Attacks resolve completely within 5 day onset menses , i.e. , symptom attack At least 4 6 attack 6 month prior entry More half attack must meet following criterion : Readily distinguishable menstrual cramp premenstrual syndrome Required hospitalization narcotic analgesic , phenothiazine , hematin , intravenous fluid , treatment Luteal attack require hospitalization must similar symptom differ severity No lifethreatening porphyria attack No cyclic abdominal pain unless cause porphyria Prior/Concurrent Therapy At least 6 month since ovulation suppression Patient Characteristics Reproductive : Menstrual cycle 2535 day least 6 month prior entry Pelvic exam normal within 60 day prior entry Pap smear normal , i.e. , dysplasia No amenorrhea No menstrual abnormality No gynecologic abnormality Negative pregnancy test Medically approve contraception require 2 month prior entry throughout study OR least 1 menstrual cycle follow tubal ligation Other : No allergy gonadotropinreleasing hormone analogues No clinically significant abnormal laboratory test result No medical contraindication protocol treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>inborn error metabolism</keyword>
	<keyword>porphyria</keyword>
	<keyword>rare disease</keyword>
</DOC>